Announce Date | 11/05/2024 |
EPS Normalized Actual | $0.41 (Miss by $-1.42) |
EPS GAAP Actual | $0.41 (Miss by $-1.42) |
Revenue Actual | $0.617899B |
Revenue Surprise | Beat by $617.899M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $4.64398 |
EPS GAAP Estimate | $4.64398 |
Revenue Estimate | $0.61125625B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 22.68 | 5.94 | 21.30561 | 24.0584 | 1 |
Dec 2026 | 17.325 | 7.78 | 14.5 | 20.15 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2024 (Sep 2024) | -0.34 | -1.88141 | 0.617899B | 100% | -871.3M |
FQ2 2024 (Jun 2024) | 0.82 | 0.82 | 0.608751B | 100% | 608.75M |
FQ1 2024 (Mar 2024) | 3.05 | 3.05 | 0.68019B | 100% | 680.19M |
FQ4 2023 (Dec 2023) | 6.26 | 6.26 | 0.774017B | 100% | 774.02M |
FQ3 2022 (Sep 2022) | 9.84 | 9.84 | 0.863835B | 31.19% | 863.84M |
FQ2 2021 (Jun 2021) | 1.82 | 1.82 | 0.450389B | 100% | 450.39M |
FQ3 2021 (Sep 2021) | 5.83 | 5.83 | 0.594412B | 100% | 594.41M |
FQ1 2022 (Mar 2022) | 17.6 | 17.6 | 0.867936B | 100% | 867.94M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
4.64398
Consensus Revenue Estimates
0.61125625B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 5.02 | -- | 4.60519 | 5.38986 | 0 |
FQ3 2026 (Jul 2026) | 5 | -- | 4.58684 | 5.36838 | 0 |
FQ2 2026 (Jun 2026) | 5 | -- | 4.56709 | 5.4885 | 0 |
FQ1 2026 (Mar 2026) | 5.04 | -- | 4.60363 | 5.53241 | 0 |
FQ4 2025 (Oct 2025) | 4.99443 | -- | 4.58173 | 5.3624 | 1 |
FQ3 2025 (Jul 2025) | 4.9038 | 106.93 | 4.49859 | 5.2651 | 1 |
FQ2 2025 (Jun 2025) | 4.64398 | 82.34 | 4.2419 | 5.0977 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.67B | -- | 0.62B | 0.7B | 1 |
FQ3 2026 (Jul 2026) | 0.65B | -- | 0.61B | 0.69B | 1 |
FQ2 2026 (Jun 2026) | 0.65B | -- | 0.61B | 0.7B | 0 |
FQ1 2026 (Mar 2026) | 0.67B | -- | 0.62B | 0.72B | 0 |
FQ4 2025 (Oct 2025) | 0.64B | -- | 0.6B | 0.68B | 0 |
FQ3 2025 (Jul 2025) | 0.63B | 1.33 | 0.59B | 0.66B | 0 |
FQ2 2025 (Jun 2025) | 0.61B | 0.41 | 0.57B | 0.66B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2024 (Sep 2024) | 1.54141 | -0.34 | -1.88141 | 553.36% |
FQ2 2024 (Jun 2024) | 0.82 | 0.82 | 100% | |
FQ1 2024 (Mar 2024) | 3.05 | 3.05 | 100% | |
FQ4 2023 (Dec 2023) | 6.26 | 6.26 | 100% | |
FQ3 2022 (Sep 2022) | 9.84 | 9.84 | 100% | |
FQ2 2021 (Jun 2021) | 1.82 | 1.82 | 100% | |
FQ3 2021 (Sep 2021) | 5.83 | 5.83 | 100% | |
FQ1 2022 (Mar 2022) | 17.6 | 17.6 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2024 (Sep 2024) | $1.49B | $0.62B | $-871.3M | -141.01% |
FQ2 2024 (Jun 2024) | $0B | $0.61B | $608.75M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.68B | $680.19M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.77B | $774.02M | 100% |
FQ3 2022 (Sep 2022) | $0B | $0.86B | $863.84M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.45B | $450.39M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.59B | $594.41M | 100% |
FQ1 2022 (Mar 2022) | $0B | $0.87B | $867.94M | 100% |